Patent · US Active

Method for the production of adenoviral vectors

US10041049B2 · kind B2 · utility

0Cited by
42References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 29, 2009
Grant dateAug 7, 2018
Priority date
Expiry dateOct 29, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides methods for large-scale production of recombinant adenovirus 35, using perfusion systems and infection at very high-cell densities.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.